|
Dec 8
|
FluoGuide Raises SEK 12 million through Exercise of Warrants
|
|
Nov 29
|
FluoGuide A/S Publishes Interim Report for the Period January - September 2023
|
|
Nov 13
|
FluoGuide Announces FG001 Meets Primary Endpoint in Phase llb Trial in Aggressive Brain Cancer
|
|
Oct 3
|
FluoGuide receives FDA Orphan Drug Designation for FG001 in High-Grade Glioma
|